SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-06-112934
Filing Date
2006-05-15
Accepted
2006-05-15 17:07:25
Documents
6
Period of Report
2006-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 406952
2 AMENDMENT TO LOAN AND SECURITY AGREEMENT dex1026.htm EX-10.26 31537
3 CERTIFICATION REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) OF HAROLD E. SELICK dex311.htm EX-31.1 8477
4 CERTIFICATION REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) OF JANET I. SWEARSON dex312.htm EX-31.2 8487
5 CERTIFICATION PURSUANT TO 18 U.S.C SECTION 1350 OF HAROLD E.SELICK dex321.htm EX-32.1 3456
6 CERTIFICATION PURSUANT TO 18 U.S.C SECTION 1350 OF JANET I.SWEARSON dex322.htm EX-32.2 3454
  Complete submission text file 0001193125-06-112934.txt   463767
Mailing Address 1300 SEAPORT BOULEVARD REDWOOD CITY CA 94063
Business Address 1300 SEAPORT BOULEVARD REDWOOD CITY CA 94063 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51136 | Film No.: 06842598
SIC: 2834 Pharmaceutical Preparations